SCHEMBL20867201

SCHEMBL20867201

Cn1cc(-c2nc(C(=N)OC(=N)NC3N=C(c4ccccc4)c4ccccc4NC3=O)c(N3CCOCC3)s2)cn1

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 16/20 0.46
▸ CCKAR P32238 6/20 0.40
▸ CCKBR P32239 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866678 1.00 CBLB (0.46) CBLBCCKARCCKBR
SCHEMBL20867195 0.92 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL20867293 0.92 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL20866899 0.89 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL24612115 0.89 CBLB (0.48) CBLBCCKARCCKBR
SCHEMBL20866881 0.89 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL20866814 0.89 CBLB (0.51) CBLBCCKARCCKBR
SCHEMBL24612096 0.89 CCKAR (0.48) CBLBCCKARCCKBR
SCHEMBL20867091 0.88 CBLB (0.49) CBLBCCKARCCKBR
SCHEMBL20867292 0.88 CBLB (0.47) CBLBCCKARCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback